NZX 50 falls as investors want more from Chorus; Infratil dips
New Zealand's S&P/NZX 50 index fell 0.7% as Chorus declined 5.3% after its earnings outlook missed expectations, while Fisher & Paykel Healthcare rose 1.6% following upgraded price targets. Infratil dropped 2.1%, and SkyCity Entertainment Group surged 9.9% on potential takeover interest. Asian markets also declined, led by Alibaba's 9.8% drop.
How this was made

The 30-second read
Why it matters
Sector‑specific earnings and guidance releases drove divergent moves among NZX constituents.
Market read
Mixed earnings and guidance outcomes created a split performance across NZX stocks, with the index down 0.7%.
What to watch
Potential spill‑over from Alibaba AI funding concerns could weigh on broader tech‑related stocks.
Background
The NZX 50 fell amid a broad Asian sell‑off, with Alibaba's AI funding raise prompting risk aversion.
Ticker impact
Fisher & Paykel Healthcare saw its price target raised to $46.90‑$51 and its stock rose 1.6% after upgraded guidance.
moderate upside in the near term
Analyst upgrades and price target lift often precede further price gains.
Market effects
Data‑centre and infrastructure stocks face pressure, while healthcare and infrastructure services see upside.
NZ market underperformed Asia, driven by local earnings and sector news.
Limited; primarily affects New Zealand‑listed equities.
Counterpoint
Despite Chorus' soft outlook, its stable earnings and dividend may attract value buyers.
Key entities
- companyChorus Limited
Broadband network operator
- companyFisher & Paykel Healthcare
Medical device maker
- companyInfratil
Data‑centre investor
- companySkyCity Entertainment Group
Casino operator
- companyVentia Services
Infrastructure maintenance firm



